Kirkland & Ellis LLP issued the following announcement on Oct. 1.
Kirkland & Ellis LLP is pleased to announce that 151 attorneys have been promoted to partner effective today.
Austin
Name
| Practice Area
|
Emily Lichtenheld
| M&A/Private Equity
|
Brice Lipman
| M&A/Private Equity
|
Patrick V. Salvo
| M&A/Private Equity
|
Kate Rainey Willson
| M&A/Private Equity
|
Bay Area
Name
| Practice Area
|
James Brownstein
| M&A/Private Equity
|
James Devereux
| Investment Funds
|
Jana Glock
| M&A/Private Equity
|
Amber Harezlak
| Technology & IP Transactions
|
Eva Mak
| M&A/Private Equity
|
Rachel O’Brien
| Investment Funds
|
Andrew D. Walker
| M&A/Private Equity
|
Emma Whenham
| Investment Funds
|
Boston
Name
| Practice Area
|
Daniel S. Connelly
| M&A/Private Equity
|
Benjamin J. Dionne
| M&A/Private Equity
|
Kyle E. Garry
| Investment Funds
|
Anne Marie Martin
| Investment Funds
|
Julia S. Sternman
| Investment Funds
|
Daniel W. Vaczy
| M&A/Private Equity
|
Chicago
Name
| Practice Area
|
Jonathan N. Adair
| Litigation
|
Valentine Bleicher
| M&A/Private Equity
|
Nick Carreri
| Investment Funds
|
Michael J. Conroy
| Tax
|
Matthew C. Darch
| Technology & IP Transactions
|
Jonathan A. Dhanawade
| M&A/Private Equity
|
Jaimie Fedell
| Restructuring
|
Melesa A. Freerks
| M&A/Private Equity
|
Miles Johnson
| Tax
|
Kyle M. Kantarek
| IP Litigation
|
Katie R. Lencioni
| Litigation
|
Kyle P. McHugh
| M&A/Private Equity
|
Kristen E. Molloy
| M&A/Private Equity
|
Noah M. Mullin
| Investment Funds
|
Kat Murphy
| M&A/Private Equity
|
Brett R. Nelson
| M&A/Private Equity
|
Kevin Pavloski
| Investment Funds
|
Tim Pickert
| Litigation
|
Jesse Lee Reising
| Litigation
|
Jeremy D. Roux
| IP Litigation
|
Daniel S. Schwimmer
| Debt Finance
|
Jeffrey J. Seroogy
| Technology & IP Transactions
|
Zharna Shah
| Litigation
|
Brandon D. Stone
| Litigation
|
Sam Stucker
| M&A/Private Equity
|
Jenna M. Stupar
| Litigation
|
Frances G. Tompson
| Executive Compensation
|
Joel E. Weinberger
| Asset Finance & Securitization
|
Matthew Whited
| M&A/Private Equity
|
Sam Zeller
| M&A/Private Equity
|
Dallas
Name
| Practice Area
|
Camille Bacon-Schulte
| Real Estate
|
Ben A. Barnes
| Litigation
|
Ben Hardison
| M&A/Private Equity
|
Shan A. Khan
| Debt Finance
|
Danny Nappier
| M&A/Private Equity
|
Jack R. Shirley
| M&A/Private Equity
|
Rami Totari
| M&A/Private Equity
|
Hong Kong
Name
| Practice Area
|
Ethan Y. Chen
| Capital Markets
|
Nicholas Liew
| Investment Funds
|
Houston
Name
| Practice Area
|
Alexandra Caritis
| Litigation
|
Tabitha De Paulo
| Litigation
|
James Dolphin
| Environmental Transactions
|
Brandon C. Elliott
| Debt Finance
|
Jennifer R. Gasser
| M&A/Private Equity
|
Daniel P. Gross
| IP Litigation
|
Mark Holden
| Litigation
|
Lindsey M. Jaquillard
| M&A/Private Equity
|
Atma Kabad
| Capital Markets
|
Paul R. Knowlton
| M&A/Private Equity
|
Hamish R. McCormack
| Debt Finance
|
Stephen S. Noh
| M&A/Private Equity
|
Ty'Meka M. Reeves-Sobers
| Environmental Transactions
|
Samara Sanderson
| Investment Funds
|
Randy S. Santa Ana
| M&A/Private Equity
|
Rebekah McEntire
| Litigation
|
Joshua Teahen
| M&A/Private Equity
|
Joe Tobias
| Tax
|
Matthew D. Turner
| Capital Markets
|
London
Name
| Practice Area
|
Samita T. Ali-Khan
| Capital Markets
|
Stefan Arnold-Soulby
| Debt Finance
|
Kanesh Balasubramaniam
| Debt Finance
|
Henry Birch
| M&A/Private Equity
|
Nick-Raj Birdi
| M&A/Private Equity
|
Ian Clarke
| Restructuring
|
James Collins
| Debt Finance
|
Hannah Crawford
| Restructuring
|
Agne (AJ) Eriksson
| Investment Funds
|
Philipp Gnatzy
| Antitrust & Competition
|
James Hunn
| M&A/Private Equity
|
Zach Milloy
| Financial Services Regulatory
|
Cillian Moynihan
| M&A/Private Equity
|
John Patten
| Technology & IP Transactions
|
Peter Pereira | IP Litigation |
Katerina Syomina | Investment Funds |
Athina Van Melkebeke | Antitrust & Competition |
Art Ward
| Tax
|
Kai Zeng
| Restructuring
|
Los Angeles
Name
| Practice Area
|
Marcy Blattner
| Litigation
|
Saghar Esfandiarifard
| Litigation
|
Matthew Gamsin
| Litigation
|
Paul Kang, Jr.
| Debt Finance
|
Michael Lee
| Investment Funds
|
Matthew N. Leist
| Debt Finance
|
J. Patrick Park
| IP Litigation
|
Lindsey Y. Shi
| IP Litigation
|
Brook Sutton
| Investment Funds
|
Christopher A. Urruela Stauss
| Investment Funds
|
Munich
Name
| Practice Area
|
Dr. Sebastian Häfele
| M&A/Private Equity
|
Dr. David Huthmacher
| M&A/Private Equity
|
New York
Name
| Practice Area
|
Gilad Bendheim
| Litigation
|
East Goitom Berhane
| Debt Finance
|
Lindsay M. Borgeson
| M&A/Private Equity - Healthcare
|
Jonathan D. Brit
| IP Litigation
|
Christopher Burwell
| M&A/Private Equity
|
Daniel R. Cellucci
| Litigation
|
Sarah E. Curry
| Capital Markets
|
Alexander C. Cushman
| Debt Finance
|
James B. Dickson
| Debt Finance
|
Jake A. Ebers
| Executive Compensation
|
Allison Gallagher
| Capital Markets
|
Jeffrey R. Goldfine
| Litigation
|
Christopher Ilardi
| IP Litigation
|
Jaye Kasper
| M&A/Private Equity
|
April Larkin
| M&A/Private Equity
|
Eduardo M. Leal
| M&A/Private Equity
|
Kurt Lyn
| M&A/Private Equity
|
Mark C. McLennan
| IP Litigation
|
Kevin M. Neylan, Jr.
| Litigation
|
Steven Ort
| Tax
|
Eric L. Perelman
| Investment Funds
|
Evangelia Podaras
| Employment & Labor
|
Noah Qiao
| Investment Funds
|
Damien J. Rose
| Tax
|
Tobias Dylan Schad
| M&A/Private Equity
|
Sarah J. Schultes
| Litigation
|
Adarsh Varghese
| M&A/Private Equity
|
Lanre Williams
| Real Estate
|
Matthew Wood
| Executive Compensation
|
Jabir Yusoff
| Executive Compensation
|
Paris
Name
| Practice Area
|
Sonia Bouaffassa
| Tax
|
Emmanuel Enrici
| M&A/Private Equity
|
Louis Gosset
| M&A/Private Equity
|
Washington D.C.
Name
| Practice Area
|
Lucille Hague
| International Trade & National Security |
Andrew C. Lawrence
| Appellate |
Emily Merki Long
| Litigation
|
T.J. McCarrick
| Litigation
|
Samantha R. Morelli
| Antitrust & Competition
|
K. Ross Powell
| Litigation
|
Joseph C. Schroeder
| Litigation
|
Carrie Schroll
| International Trade & National Security
|
C. Alex Shank
| IP Litigation
|
Sarah Smith
| Litigation
|
McClain Thompson
| Litigation
|
Note: For certain partners, admission will take effect when any necessary regulatory requirements have been satisfied.